| |
|
| |
| |
 |
| |
| Forthcoming events |
Duncan Curley will be leading a workshop entitled ‘In-depth analysis of Supplementary Protection Certificates’ on 18 September 2008 as part of the ViB 8th Annual Pharma Law Europe Conference in London.
Please see www.pharmalaw-events.com/workshop.htm for further details. |
| |
| Previous events |
| On 14 May 2008, Duncan Curley ran a half day Executive Briefing on Patent Issues in the Development of Biosimilar Medicines, as part of the eleventh annual SMi Conference on Generics, Supergenerics and Patent Strategies in London (see photographs below). |
| |
| Innovate Legal will re-run this workshop briefing, on request. For further details, please contact our Head of Projects, Simon Barnham, either by email (simonbarnham@innovatelegal.co.uk) or by telephone (+44(0)20 7936 9286). For further details of the workshop programme, please see below. |
|
| |
| SESSION ONE |
| An overview of the commercial and regulatory landscape |
 |
The first wave of biosimilar medicines |
|
The second wave: 2010 and beyond |
|
Patent law basics |
|
|
|
| SESSION TWO |
| Erythropoietin |
|
Commercial overview |
|
The Dynepo® litigation |
|
Lessons from the public record: Aranesp® |
|
|
|
| SESSION THREE |
| Case Studies: insulin and G-CSF |
|
Recombinant insulin: commercial overview |
|
A closer look at insulin glargine |
|
G-CSF: commercial overview |
|
Lenograstim and PEGylated G-CSF (Neulasta®) |
|
|
|
|
|
|
| |
|
|
